Medical genetics: 5 PE-backed deals

Archimed, KKR and Novo Holdings are among the PE firms investing in pharma research, development and sales for genetic medicine.

ByJohn R Fischer

17 January 2025•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Featured Europe North America UK US Western Europe Healthcare Top Stories